Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer

[1]  W. Greenleaf,et al.  Single-cell transcriptomic landscape of the developing human spinal cord , 2023, Nature Neuroscience.

[2]  Daniele Di Mauro,et al.  UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus. , 2023, Journal of autoimmunity.

[3]  M. Amacker,et al.  A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge , 2023, Scientific Reports.

[4]  Geng Tian,et al.  ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data , 2022, Briefings Bioinform..

[5]  Ju Xiang,et al.  DGHNE: network enhancement-based method in identifying disease-causing genes through a heterogeneous biomedical network , 2022, Briefings Bioinform..

[6]  Geng Tian,et al.  Predicting colorectal cancer tumor mutational burden from histopathological images and clinical information using multi-modal deep learning , 2022, Bioinform..

[7]  J. Wang,et al.  Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern , 2022, ACS infectious diseases.

[8]  G. Morahan,et al.  Cancer susceptibility genes: update and systematic perspectives , 2022, Innovation (Cambridge (Mass.)).

[9]  S. Soliman,et al.  COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities , 2022, Gene Reports.

[10]  Masahiro Wakao,et al.  Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects. , 2022, ACS chemical biology.

[11]  J. Wang,et al.  Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine , 2022, Frontiers in Immunology.

[12]  Xiangxiang Zeng,et al.  A weighted bilinear neural collaborative filtering approach for drug repositioning , 2022, Briefings Bioinform..

[13]  Geng Tian,et al.  Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning , 2021, Computational and structural biotechnology journal.

[14]  Ping Li,et al.  Deep-Tissue Fluorescence Imaging Study of Reactive Oxygen Species in a Tumor Microenvironment. , 2021, Analytical chemistry.

[15]  A. Khalifa,et al.  Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19 , 2021, Current Research in Pharmacology and Drug Discovery.

[16]  R. Rizzo,et al.  TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection , 2021, Microorganisms.

[17]  Tao Huang,et al.  Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review , 2021, The Innovation.

[18]  S. Ludovisi,et al.  Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study , 2021, eLife.

[19]  Xiaoping Wu,et al.  Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019 , 2021, Frontiers in Oncology.

[20]  Lijun Cai,et al.  Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19 , 2021, Frontiers in Immunology.

[21]  Jialiang Yang,et al.  An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression , 2020, Molecular therapy. Nucleic acids.

[22]  A. Oza,et al.  COVID-19 Testing in Patients with Cancer: Does One Size Fit All? , 2020, Clinical Cancer Research.

[23]  Chenqi Xu,et al.  Immune checkpoint signaling and cancer immunotherapy , 2020, Cell Research.

[24]  G. Superti-Furga,et al.  TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9 , 2020, Nature.

[25]  K. Farsalinos,et al.  Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19 , 2020, Environmental Research.

[26]  H. Kourie,et al.  Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence , 2020, Critical Reviews in Oncology/Hematology.

[27]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[28]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[29]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[30]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[31]  J. Rehwinkel,et al.  Deoxyguanosine is a TLR7 agonist , 2019, European journal of immunology.

[32]  Adrian V. Lee,et al.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.

[33]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[34]  Toshiyuki Shimizu,et al.  Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA. , 2016, Immunity.

[35]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[36]  Gabriele Schackert,et al.  DNA methylation profiles of long- and short-term glioblastoma survivors , 2013, Epigenetics.

[37]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[38]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[39]  Thomas Lengauer,et al.  A DNA methylation fingerprint of 1628 human samples. , 2011, Genome research.

[40]  C. Schmitz,et al.  Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides. , 2011, Nucleic acid therapeutics.

[41]  Rajeev Kumar,et al.  Receiver operating characteristic (ROC) curve for medical researchers , 2011, Indian pediatrics.

[42]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[43]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[44]  L. Parker,et al.  Translational Mini‐Review Series on Toll‐like Receptors:
Networks regulated by Toll‐like receptors mediate innate and adaptive immunity , 2007, Clinical and experimental immunology.

[45]  Shizuo Akira,et al.  Signaling to NF-kappaB by Toll-like receptors. , 2007, Trends in molecular medicine.

[46]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[47]  Jongdae Lee,et al.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.